HK
Hampar Karageozian, MSc, MBA
Co-Founder, Chief Technology Officer and Chairman Emeritus
Allegro OphthalmicsTherapeutic Areas
Allegro Ophthalmics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Risuteganib (Luminate®) | Intermediate Dry Age-Related Macular Degeneration (AMD) | Phase 2b/3 |
| ALG-1007 | Dry Eye Disease (DED) | Pre-clinical/Phase 1 |